Our data also showed that both the Glial fibrillary acidic protein (GFAP) and ionized calcium-binding adaptor molecule 1 (Iba-1) markers in the neuronal tissue homogenate were significantly increased in AD, and the treatment with NMP prominently reduced the expression of these markers. This evidence concerns the gene GFAP and Alzheimer disease.